Medinova Pharma

Orligal is indicated in conjunction with a mildly hypocaloric diet for the treatment of obese patients with a body mass index (BMI) greater or equal to 30 kg/m², or overweight patients (BMI ≥ 28 kg/m²) with associated risk factors. Treatment with Orligal should be discontinued after 12 weeks if patients have been unable to lose at least 5 % of the body weight as measured at the start of therapy.

Orlistat 120mg Tablet is a medicine used in the treatment of obesity. It helps the body in blocking the absorption of fats from the small intestines and stomach. This way it can help reduce calorie intake and weight loss over time.

Orlistat 120mg is a medication used to aid in weight loss by preventing the absorption of fats from the diet. It is typically prescribed alongside a reduced-calorie diet and regular exercise to treat obesity. Orlistat works by inhibiting the enzyme lipase, which is responsible for breaking down dietary fats in the intestines. Common side effects may include abdominal cramping, flatulence, and oily stools. It is available by prescription as Xenical and over-the-counter as Alli in lower doses.